Life sciences capabilities
The business of vital innovation
How we can help you
Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
19 марта 2026
Pharmaceuticals: Deals revival
19 марта 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
12 марта 2026
Pharma: Key UK legal developments from 2025
12 февраля 2026
UPC Court Fees
12 февраля 2026
Corporate Crime 360: Your complete guide to APAC trends in 2026
11 февраля 2026
2026 Employment and Workplace Relations in Australia Legal Guide
15 января 2026
Two and a half years of the UPC – Trends and turning points
19 декабря 2025
Treasury Updates Merger Rules
19 декабря 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
19 декабря 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
31 октября 2025
High bar for material adverse change in M&A: Lessons from the Mayne Pharma / Cosette decision
18 сентября 2025
Are you cyber ready? The cyber challenge through the eyes of Australia’s legal leaders
Key contacts
Alan Montgomery
Partner, Head of Life Sciences Sector, Chair of India Group, London
Chris Parker KC
Partner, Head of Life Sciences Sector, London
Natalie Bryce
Partner, Head of Healthcare Sector, Brisbane